Have you been diagnosed with a brain tumour? Order your free information pack.

What we’re campaigning for

Policy-makers discuss key decisions every day that can have an impact on our community. That means that politics plays a big part in what we do. We influence policy-makers at every level, whether that’s by accelerating patient’s access to new drugs or by lobbying for more investment for research into brain tumours.

the cost of a brain tumour: the urgent case for economic action

The Cost of a Brain Tumour: The Economic Case for Urgent Action

New economic analysis reveals the true personal and economic burden of brain tumour diagnoses in 2025.

Web banner for the National Brain Tumour Strategy - It's a No Brainer. It reads: It's Time to Improve Brain Tumour Care

National Brain Tumour Strategy

We’re calling for the Government to create a National Brain Tumour Strategy to provide better care to people affected.

Steph from our Policy and Campaigns team speaking to MP’s in Westminster, London

Fighting for Faster Diagnosis

Find out more about our Fighting for Faster Diagnosis campaign.

NHS logo

Have your say

Your voice could help shape the future of cancer care in England

Our work in Scotland

We will continue to campaign in Scotland to ensure that our community’s voice is heard.

Our work in Wales

We will continue to campaign in Cymru to ensure that our community’s voice is heard.

LSCT

We’re committed to improving survival rates for people affected by less survivable cancers.

Welfare and benefits

Ensuring fair access to welfare and benefits for those in need is one of our priorities.

Tessa Jowell

A steering committee focusing on research, clinical trials, training and patient experience.

Equal Access

Everyone affected should have equal access to high quality treatment, care and information.

Our Better Safe Than Tumour campaign

Better Safe Than Tumour is our UK-wide campaign to reduce diagnosis times of brain tumours.

Cancer52 logo

Cancer52 Alliance

We’re proud members of Cancer52, a coalition aiming to improve outcomes for people affected by rare and less common cancers.